Pharma Focus Asia
KP - Sustainable Packaging Solutions

Lek Invests US$400 mn for the Construction of Biopharmaceutical Production Centre in Slovenia, Europe


Lek will invest US$400 million for the construction of an advanced biopharmaceutical production centre in Slovenia, Europe.


The facility will feature cutting-edge production and storage facilities, with a combined surface area totalling 40,000 square metres.

The first of three facilities planned at Lek's current site in Lendava will be dedicated to producing energy products for the ongoing production while also addressing the future centre's demands for the production of drug substances used in biosimilars.

The new biosimilars production centre will enhance manufacturing capabilities and provide crucial support to propel the future expansion of the global biosimilar portfolio. 

Once fully operational, the site will play a vital role in producing the necessary drug substances for biosimilars, catering to the treatment needs of patients in the areas of rheumatology, oncology, and immunology.

The facility is anticipated to commence operations by the end of 2026.


Name        Lek
Type          New Construction
Budget     US$400 million
Year          2026

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?